AstraZeneca has agreed to take a $2-billion equity stake in Summit Therapeutics, a Miami-based bio/pharmaceutical company, and the companies have formed a clinical collaboration to evaluate Summit’s ...

Novo has entered into a license agreement with Hengrui Pharma, a Shanghai-based bio/pharmaceutical company, for HRS-1596, a Phase I-ready glucagon-like peptide-1 receptor (GLP-1R) and gastric ...

Sanofi has expanded its antibody collaboration with Regeneron Pharmaceuticals, a Tarrytown, New York-based bio/pharmaceutical company, to add four new drug candidates in an $8-billion deal ($1 billion ...

The White House is moving to identify new and unused domestic, US-based, and near-shore production capacity to meet a goal of localizing manufacturing of essential medicines. The White House is moving ...

What is the state-of-the state for biomanufacturing (drug substance) in terms of industry capacity utilization, in-sourced/outsourced activity, and technology drivers? Is capacity in line with demand ...

The latest from CDMOs, CMOs, and suppliers featuring SK pharmteco, Esteve CDMO, Vetter, Sharp Services, Piramal Pharma Solutions, SPI Pharma, Colorcon, Lonza, and Bespak. Chemicals/Chemical API ...

Roche’s Genentech has broken ground on a $750-million, 211,000-square-foot expansion of its manufacturing facility in Hillsboro, Oregon, to add device fill–finish capabilities, including the ...

How are small-molecules faring in 2026? To answer that question, DCAT Value Chain Insights examined where the small-molecules drugs among the 11 drugs identified by Clarivate, a business intelligence ...

Novo’s CEO Mike Doustdar laid out a strategic growth plan for the company, which included a plan to launch more than five ...

The European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents bio/pharmaceutical innovator companies and national pharmaceutical trade associations, issued a ...